Richardson Jean L, Nowicki Marek, Danley Kathleen, Martin Eileen M, Cohen Mardge H, Gonzalez Raul, Vassileva Jasmin, Levine Alexandra M
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
AIDS. 2005 Oct 14;19(15):1659-67. doi: 10.1097/01.aids.0000186824.53359.62.
To evaluate the neurocognitive function in 220 women enrolled in the Women's Interagency HIV Study (WIHS), a study of disease progression in women living with HIV/AIDS and in HIV-negative controls.
We evaluated the prevalence of abnormal neuropsychological (NP) results in hepatitis C virus (HCV)-positive compared with HCV-negative women in combination with HIV serostatus.
NP impairment was significantly higher for HCV-positive women in comparison with HCV-negative women [odds ratio (OR), 2.03; 95% confidence interval (CI), 1.17-3.51]. Women co-infected with HCV and HIV demonstrated greater abnormal NP performance than those not infected with either, particularly if there was evidence of CD4 T-lymphocyte immunosuppression [> 200 x 10(6) CD4 cells/l (OR, 3.48; 95% CI, 1.49-8.15) and < or = 200 x 10(6) CD4 cells/l (OR, 5.38; 95% CI, 1.46-19.84)]. Women who were HCV-positive/HIV-positive and not taking antiretroviral therapy (ART) were more likely (OR, 7.03; 95% CI, 2.63-18.82) to demonstrate NP impairment than those who were HCV-negative/HIV-negative. In analyses controlling separately for education, intelligence quotient, depression, sedating drug use, head injury, ethnicity, and history of substance use, HCV continued to significantly predict NP impairment. The HCV effect did not reach significance when controlling for age in bivariate or multivariate analyses although the odds ratio for NP abnormalities in HCV-infected patients was only slightly reduced (ORs above 1.9). After testing for an interaction between age and infection status, we conducted age-stratified analysis and showed a significant effect of infection status for those aged under 40 years.
The effect of aging on co-infected populations will require further study. This study has demonstrated the association of HCV with the risk of neurocognitive impairment in women living with HIV/AIDS and suggests that co-infection has an additive effect.
评估参与女性机构间HIV研究(WIHS)的220名女性的神经认知功能,该研究旨在调查感染HIV/AIDS的女性及HIV阴性对照者的疾病进展情况。
我们结合HIV血清学状态,评估丙型肝炎病毒(HCV)阳性女性与HCV阴性女性神经心理学(NP)异常结果的患病率。
与HCV阴性女性相比,HCV阳性女性的NP损害显著更高[比值比(OR)为2.03;95%置信区间(CI)为1.17 - 3.51]。同时感染HCV和HIV的女性比未感染任何一种病毒的女性表现出更严重的NP异常,特别是如果有CD4 T淋巴细胞免疫抑制的证据[>200×10⁶个CD4细胞/升(OR为3.48;95%CI为1.49 - 8.15)及≤200×10⁶个CD4细胞/升(OR为5.38;95%CI为1.46 - 19.84)]。HCV阳性/HIV阳性且未接受抗逆转录病毒治疗(ART)的女性比HCV阴性/HIV阴性的女性更有可能(OR为7.03;95%CI为2.63 - 18.82)出现NP损害。在分别控制教育程度、智商、抑郁、使用镇静药物、头部损伤、种族和药物使用史的分析中,HCV仍然是NP损害的显著预测因素。在双变量或多变量分析中控制年龄时,HCV的影响未达到显著水平,尽管HCV感染患者NP异常的比值比仅略有降低(OR高于1.9)。在检测年龄与感染状态之间的相互作用后,我们进行了年龄分层分析,结果显示感染状态对40岁以下人群有显著影响。
衰老对合并感染人群的影响需要进一步研究。本研究证明了HCV与感染HIV/AIDS的女性神经认知损害风险之间的关联,并表明合并感染具有叠加效应。